HCPLive Network


Physicians remain the biggest influence on whether patients get vaccinated, and must be prepared to address patients' reservations, according to an article published in the March/April issue of Family Practice Management.
Noting the management and treatment of postherpetic neuralgia (PHN) are currently subpar in the primary care setting, 2 researchers recently reviewed and outlined key clinical considerations for the chronic neuropathic pain syndrome.
Oseltamivir and zanamivir reduce the time to symptomatic improvement in influenza by about half a day, but evidence to support claims of reduced admissions to hospital or complications of influenza is lacking, according to two systematic reviews of regulatory information published online April 10 in BMJ.
The FDA has granted Bexsero, a meningococcal group B vaccine, breakthrough therapy status.
The antiviral drug Tamiflu (oseltamivir) reduced the risk of death by 25 percent among adults hospitalized during the 2009 H1N1 swine flu pandemic, according to a review published online March 19 in The Lancet Respiratory Medicine. In addition, antiviral treatment within 48 hours of developing flu symptoms halved the risk of death compared with starting treatment later or receiving no treatment.
For young women attending sexual health services in England, human papillomavirus vaccination uptake and completion rates are lower than national data, with an overall completion rate of 47 percent, according to a study published online March 17 in Sexually Transmitted Infections.
Vaccination Upcoming Events
Vaccination Resources